子宫内膜癌术后辅助治疗方法研究进展

Research progress in postoperative adjuvant therapy of endometrial carcinoma

子宫内膜癌是女性生殖系统常见恶性肿瘤之一。其治疗原则一般首选手术治疗，术后根据肿瘤手术病理分期、组织学分级等高危因素选择适当的辅助治疗方案，如术后给予放疗、化疗以及同步放化疗等。子宫内膜癌术后根据患者个体化情况，酌情选择适宜的术后辅助治疗，可有效提高患者的无瘤生存率及远期生存率。但目前对子宫内膜癌术后辅助治疗方法的选择存在较多争议，本文对近年来子宫内膜癌术后辅助治疗的研究进展作一综述。

Endometrial carcinoma is the most common malignancy of the female genital tract. The traditional treatment of endometrial cancer is surgical excision supplemented by radiotherapy, chemotherapy or combined radio-chemotherapy. According to the individual condition of postoperative patients with endometrial carcinoma, choosing appropriate postoperative adjuvant therapy discreetly, which can effectively improve disease-free survival and long-term survival rate. But, for patients with endometrial carcinoma, how to choose the postoperative adjuvant treatment method is still controversial. The purpose of this article is to review of the research progress of endometrial carcinoma postoperative adjuvant therapy, and summariz.